Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some observations on haemorrhagic smallpox (Type I)

M Mitra, D K Bhattacharya

    Journal of the Indian Medical Association
    |December 1, 1976
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety and efficacy of microwave ablation of lung tumours close to the heart and aorta.

    Clinical radiology·2026
    Same author

    Safety and tolerance of infant formulas containing probiotics: a multicenter, randomised, controlled trial in healthy term infants.

    Beneficial microbes·2025
    Same author

    Parents with physical disabilities and their parenting experiences: a scoping review of qualitative studies.

    Disability and rehabilitation·2025
    Same author

    A unique approach for protein secondary structure comparison under TOPS representation.

    Journal of biomolecular structure & dynamics·2024
    Same author

    Biochemical Property Based Positional Matrix: A New Approach Towards Genome Sequence Comparison.

    Journal of molecular evolution·2022
    Same author

    Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study.

    Vaccine: X·2022